乳腺癌被动散射质子治疗后放射性皮炎预后因素
本回顾性研究纳入2012至2016年接受被动散射质子治疗的23例乳腺癌患者,每次1.8或2 CGE,总剂量50-50.4 CGE。43%患者发生3级放射性皮炎,皮肤5mm的V52.5CGE和D10cm3在单因素和多因素分析中均与3级皮炎相关,联合吸烟史可提高预测性能。
要点
- 43%的患者发生3级放射性皮炎。
- 皮肤5mm的V52.5CGE和D10cm3是3级皮炎的预后因素。
- 联合吸烟史可提高模型预测性能。
核心结论
- 皮肤5mm的V52.5CGE和D10cm3是乳腺癌被动散射质子治疗后3级放射性皮炎的预后因素,联合吸烟史可提高预测性能。
研究设计与样本
- 回顾性研究纳入2012至2016年接受被动散射质子治疗的23例乳腺癌患者(11例乳房切除术后,12例肿块切除术后),总剂量50-50.4 CGE,每次1.8或2 CGE。
主要发现
- 43%的患者发生3级放射性皮炎。
- 皮肤5mm的D10cm3(AUC=0.69)和V52.5CGE(AUC=0.70)可预测3级皮肤毒性。
- 联合乳房体积后AUC分别 marginal 增至0.72和0.73。
- 联合吸烟史后AUC分别增至0.75和0.83。
临床怎么用
- 可利用皮肤5mm的V52.5CGE和D10cm3识别3级放射性皮炎高风险患者,以便调整治疗计划降低风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To identify prognostic factors for grade 3 radiation dermatitis following passive-scattering proton therapy for breast cancer. METHODS: This retrospective study included data on 23 (11 post-mastectomy and 12 post-lumpectomy) breast cancer patients who underwent proton therapy with the passive scattering technique in our institute from 2012 to 2016. Each patient received 50-50.4 cobalt Gy equivalent (CGE) at 1.8 or 2 CGE per daily fraction. Logistic regression analysis was performed to identify prognostic factors for grade 3 skin toxicity. Receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC) were used to evaluate the performance of the models. RESULTS: 43% of the studied patients developed grade 3 radiation dermatitis. The dose-volume histogram (DVH) parameters of V52.5CGE and D10cm3 to skin5mm were correlated with grade 3 radiation dermatitis in both univariate and multivariate logistic regression analyses. Univariate logistic regression analysis suggested that D10cm3 to skin5mm (AUC = 0.69) and V52.5CGE to skin5mm (AUC = 0.70) were prognostic for grade 3 skin toxicity. The models using the combination of D10cm3 to skin5mm or V52.5CGE to skin5mm with breast volume marginally increased the AUC to 0.72 and 0.73, respectively. Models using the combination of D10cm3 to skin5mm or V52.5CGE to skin5mm with history of smoking increased the AUC to 0.75 and 0.83, respectively. CONCLUSION: In the current study, we identified prognostic factors for grade 3 radiation dermatitis in patients treated with passive-scattering proton therapy for breast cancer. This study provides promising tool for identifying high risk patients for whom treatment plan adjustment could be done to reduce the risk of radiation-induced grade 3 skin toxicity.
引用
- Liang X, Bradley JA, Zheng D, et al. Prognostic factors of radiation dermatitis following passive-scattering proton therapy for breast cancer. Radiat Oncol. 2018. PMID: 29673384. doi:10.1186/s13014-018-1004-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。